AstraZeneca has acquired the rights to Forest Laboratories' anti-infective ceftaroline outside the US, Canada and Japan.
Ceftaroline is a next-generation cephalosporin being developed for the treatment of complicated skin and skin structure infections (cSSSI) and community-acquired...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
